摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1,1,1-Trichlor-2-aethoxy-aethan | 14799-36-1

中文名称
——
中文别名
——
英文名称
1,1,1-Trichlor-2-aethoxy-aethan
英文别名
1,1,1-trichloro-2-ethoxy-ethane;1,1,1-Trichloro-2-ethoxyethane
1,1,1-Trichlor-2-aethoxy-aethan化学式
CAS
14799-36-1
化学式
C4H7Cl3O
mdl
——
分子量
177.458
InChiKey
KVKBJTBZITVMMW-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    166.2±35.0 °C(Predicted)
  • 密度:
    1.313±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.3
  • 重原子数:
    8
  • 可旋转键数:
    2
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    9.2
  • 氢给体数:
    0
  • 氢受体数:
    1

反应信息

点击查看最新优质反应信息

文献信息

  • METHOD OF PRODUCING PYRONE AND PYRIDONE DERIVATIVES
    申请人:Sumino Yukihito
    公开号:US20120022251A1
    公开(公告)日:2012-01-26
    The present invention provides a pyrone derivative and a pyridone derivative, which are novel intermediates for synthesizing an anti-influenza drug, a method of producing the same, and a method of using the same.
    本发明提供了一种吡喃衍生物和一种吡啶酮衍生物,它们是合成抗流感药物的新型中间体,以及其制备方法和使用方法。
  • Novel oxazolidinone derivatives and a process for the preparation thereof
    申请人:——
    公开号:US20030166620A1
    公开(公告)日:2003-09-04
    The present invention relates to novel oxazolidinone derivatives, their pharmaceutically acceptable salts and a process for the preparation thereof. More particularly, the present invention relates to oxazolidinone derivatives having pyridine or pyrimidine moeity substituted by heterocycle and heteroaromaticcycle at 4-position of phenyl ring. The compounds of the present invention have wide antibacterial spectrum, superior antibacterial activity and low toxicity, such that the compound of this invention can be used as an antibacterial agent.
    本发明涉及新颖的噁唑烷酮衍生物,其药用盐以及其制备方法。更具体地,本发明涉及在苯环的4位被杂环和杂芳环取代的噁唑烷酮衍生物。本发明的化合物具有广泛的抗菌谱、优越的抗菌活性和低毒性,因此本发明的化合物可用作抗菌剂。
  • SUBSTITUTED POLYCYCLIC CARBAMOYL PYRIDONE DERIVATIVE PRODRUG
    申请人:Takahashi Chika
    公开号:US20130197219A1
    公开(公告)日:2013-08-01
    The present invention provides a compound having antiviral effects, particularly having growth inhibitory activity on influenza viruses, a preferred example of the compound being a substituted 3-hydroxy-4-pyridone derivative prodrug having cap-dependent endonuclease inhibitory activity.
    本发明提供了一种具有抗病毒效果的化合物,特别是对流感病毒具有生长抑制活性,该化合物的首选例子是一种具有依赖帽端核酸酶抑制活性的取代3-羟基-4-吡啶酮衍生物前药。
  • [EN] NOVEL OXAZOLIDINONE DERIVATIVES AND A PROCESS FOR THE PREPARATION THEREOF<br/>[FR] NOUVEAUX DERIVES OXAZOLIDINONE ET PROCESSUS DE PREPARATION DE CES DERIVES
    申请人:DONG A PHARM CO LTD
    公开号:WO2001094342A1
    公开(公告)日:2001-12-13
    The present invention relates to novel oxazolidinone derivatives, their pharmaceutically acceptable salts and a process for the preparation thereof. More particularly, the present invention relates to oxazolidinone derivatives having pyridine or pyrimidine moeity substituted by heterocycle and heteroaromaticcycle at 4-position of phenyl ring. The compounds of the present invention have wide antibacterial spectrum, superior antibacterial activity and low toxicity, such that the compound of this invention can be used as an antibacterial agent.
    本发明涉及新型噁唑烷衍生物,其药学上可接受的盐以及其制备方法。更具体地说,本发明涉及在苯环的4位上以杂环和杂芳环取代的吡啶或嘧啶基团的噁唑烷衍生物。本发明的化合物具有广泛的抗菌谱、优越的抗菌活性和低毒性,因此本发明的化合物可用作抗菌剂。
  • Novel hypotensive diuretic peptides
    申请人:SHIONOGI SEIYAKU KABUSHIKI KAISHA trading under the name of SHIONOGI & CO. LTD.
    公开号:EP0266006A2
    公开(公告)日:1988-05-04
    A polypeptide possessing the basic structure of β-hANP but lacking the 1 to 6 and 1ʹ to 6ʹ amino acid sequences, i.e. Ser-Leu-Arg-Arg-Ser-Ser, and the salts thereof, useful for the treatment of hypertensions, prepared by bimolecular condensation of α-hANP(7-28) at the 7 and 23ʹ cysteines, and at the 7ʹ and 23 cysteines, respectively, with disulfide bonds.
    一种具有β-hANP基本结构,但缺少1-6和1ʹ-6ʹ氨基酸序列(即Ser-Leu-Arg-Arg-Ser-Ser)的多肽及其盐,可用于治疗高血压,该多肽是通过双分子缩合α-hANP(7-28)的7和23ʹ半胱氨酸,以及分别在7ʹ和23半胱氨酸上的二硫键制备而成。
查看更多